119 related articles for article (PubMed ID: 17141753)
1. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
2. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
3. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
Paczkowski FA; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
[TBL] [Abstract][Full Text] [Related]
4. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
5. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
6. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
7. Cysteine at position 217 in the intracellular loop 1 plays a critical role in human PTH receptor type 1 membrane translocation and function.
Thomas BE; Wittelsberger A; Woznica I; Hsieh MY; Monaghan P; Lee BK; Rosenblatt M
J Bone Miner Res; 2007 Apr; 22(4):609-16. PubMed ID: 17227205
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
9. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
Sucic S; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
[TBL] [Abstract][Full Text] [Related]
10. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.
Lynagh T; Khamu TS; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):95-107. PubMed ID: 24081522
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Reith ME; Wang LC; Dutta AK
J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
[TBL] [Abstract][Full Text] [Related]
12. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
Plenge P; Gether U; Rasmussen SG
Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
[TBL] [Abstract][Full Text] [Related]
13. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Wang CI; Shaikh NH; Ramu S; Lewis RJ
Mol Pharmacol; 2012 Nov; 82(5):898-909. PubMed ID: 22874414
[TBL] [Abstract][Full Text] [Related]
14. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
16. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
17. Role of proline residues in the expression and function of the human noradrenaline transporter.
Paczkowski FA; Bryan-Lluka LJ
J Neurochem; 2004 Jan; 88(1):203-11. PubMed ID: 14675164
[TBL] [Abstract][Full Text] [Related]
18. Functional importance of GGXG sequence motifs in putative reentrant loops of 2HCT and ESS transport proteins.
Dobrowolski A; Lolkema JS
Biochemistry; 2009 Aug; 48(31):7448-56. PubMed ID: 19594131
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
20. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]